MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Canadian-based Harvest One Capital Corp. (CVE:WON.H) has launched a C$15 million private placement to finalise the acquisition of the Company's cannabis subsidiaries United Greeneries Holdings Ltd and Satipharm AG respectively.
(NetworkNewsWire) Once New York-based Axsome Therapeutics, Inc. (NASDAQ:AXSM) was founded in 2012, its team set out to establish a fully-integrated biopharmaceutical business that would develop therapies to treat and manage central nervous system (CNS) disorders. Now in 2017, the Axsome team is setting off on another exciting leg on this journey.
(NetworkNewsWire) Rosetta Genomics, Ltd. (NASDAQ:ROSG), a company in the business of developing and commercializing MicroRNA-based and other molecular diagnostics, recently had its 'Buy' rating restated by Aegis Capital Corp.
(NetworkNewsWire) Trevena, Inc. (NASDAQ:TRVN), a clinical stage biopharmaceutical company, on January 4 announced it had completed enrollment for its Phase 3 Apollo Pivotal Efficacy Trials of oliceridine for moderate to severe pain.
(NetworkNewsWire) Jaguar Animal Health, Inc. (NASDAQ:JAGX), a company in the business of developing and commercializing gastrointestinal products for companion animals, horses, and production animals, recently had its company outlook updated by Aegis Capital Corp.
MMJ PhytoTech Limited (ASX:MMJ) advises in accordance with Listing Rule 3.10A, that the following securities will be released from escrow on Monday, 23 January 2017.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its Canadian-based subsidiary, United Greeneries Ltd ("UG") has commenced cannabis growing operations at its state-of-the-art Duncan Facility.
